phagocytose the lipid and other cellular constituents. These molecules may activate toll-like receptors on the macrophages and neighboring adipocytes, inducing proinflammatory cytokine and chemokine releases. Cross-talk among adipocytes, macrophages and other cells promotes inflammation and ECM remodeling, as described later. The macrophages eventually assume the appearance of lipid-laden foam cells. Within weeks, the lipid and other cellular debris disappear from the adipose tissue and new, apparently healthy adipocytes populate the tissue. The time course of tissue remodeling coincides with the development and amelioration of insulin resistance ( Fig. 1 ), suggesting the remodeling process has a metabolic consequence at the organism level [4] .
Depot and sex differences in remodeling
The remarkable nearly complete remodeling of the epididymal fat does not occur in the subcutaneous (sc) (inguinal) adipose tissue of the male mouse in dietinduced obesity [4] . Adipocyte death in inguinal depot is detectable but much lower (3% compared to 80% in epidydimal at 16 weeks on high-fat diet [4] ). Similar depot differences are observed in genetic obese models [5 ] . The mechanisms underlying depot differences in rates of remodeling are poorly understood. The anatomy and growth characteristics and the composition of the ECM differ substantially among adipose depots. Whereas the sc depot grows in response to a high-fat diet mainly by increasing the number of adipocytes, the hyperplastic capacity of the visceral depot is far lower [6] . The limited adipocyte precursor pool and hence the limited capacity for hyperplasia in visceral depots may contribute to the stress on the existing adipocytes.
Adipose tissues of female mice are far less susceptible to high-fat diet-induced adipocyte death and adipose tissue remodeling. This sex difference is dramatic in the gonadal (parametrial vs. epididymal), but also holds for sc inguinal fat depots [7 ] . Compared to the gonadal depots, the sc fat showed less macrophage infiltration and the fewest number of CLS representing dead adipocytes [4, 7 ] . Whereas ovariectomy increased the numbers of CLS in both depots, the numbers were still lower [7 ], suggesting the sex difference in adipose remodeling is not entirely due to sex steroids.
Are rates of adipocyte turnover similar in human and rodent adipose tissues?
No studies have directly assessed the lifespan of adipocytes in rodents. But on the basis of the time course studies [4], under the stress of very high-fat diets/obesity, almost 80% of the adipocytes in the epididymal adipose tissue died and were replaced within a few weeks. Even in the omentum of severe obese patients, the number of CLS is much lower (absent or maximum estimate of 3% adipocytes calculated from the data in Fig. 1d of [8] with an assumption of four macrophages in one CLS), but these values are not dissimilar to the numbers in the sc of mice fed regular chow or low-fat diets.
Recent studies estimate that the lifespan of a sc adipocyte in humans is approximately 2-3 [9] or 10 years [10 ] . Methodological issues likely account for the disparate estimates, most likely due to variable contamination with nonadipocytes including macrophages in isolated adipocyte fractions [11] . Interestingly, according to the estimates resulting from a natural experiment made possible by the labeling of DNA by radioactive fallout, body mass index (BMI) and weight loss do not alter the adipocyte turnover rates [10 ] . This finding implies that adipocyte number is tightly regulated, static during adulthood and the relative rates of adipocyte death are equal between lean and obese. However, because obese individuals have more adipocytes, the absolute number of dead or dying adipocytes at any time point is higher and could contribute to the chronic inflammatory state. It is, however, conceivable that under extreme circumstances (massive or prolonged weight loss or lipoatrophy), the rate of adipocyte loss could exceed the rate at which they are replaced, decreasing the average cell half-life and leading to net loss of mature adipocytes, but experimental evidence is lacking. Due to the cross-sectional nature of this study, periods of more rapid turnover during overfeeding could also have been missed.
Potential diet effects on adipose remodeling
Many rodent studies used saturated fat as a major component of energy intake. Saturated and unsaturated fatty acids have differential effects on adipose tissue production of chemotactic factors [12] . n-3 polyunsaturated fat has been shown to prevent high-fat diet-induced adipose tissue inflammation and remodeling [13, 14] . Thus, dietary factors are important modulators of inflammatory events and potentially rates of adipocyte death and tissue remodeling. Whether dietary factors contribute to the apparent species differences in rates of adipocyte turnover observed merits further study.
What factors instigate adipose tissue remodeling and what mechanisms are involved?
Role of extracellular matrix remodeling is such that excessive stiffness of the ECM can limit adipocyte size [15 ] . ECM remodeling is required during adipocyte hypertrophy. It is mediated by fibrinolytic plasminogen and plasmin, matrix metalloproteinase (MMP), a disintegrin and metalloprotease (ADAM), and tissue inhibitors of MMP (TIMP) systems. Plasminogen activator inhibitor (PAI)-1 is highly expressed in obese adipose tissue [16] . MMPs are overexpressed in adipose tissue of obesity with increased matrix degradation (increased plasticity) [17] [18] [19] . Cathepsins may also contribute to the remodeling process through their proteolytic activity toward extracellular elastins and collagens. Expression of adipose cathepsin K and S is increased in obesity [20, 21 ] and decreases after weight loss [21 ,22] . Interestingly, MMP2, cathepsin K, and L null mice exhibit reduced adiposity [19, [23] [24] [25] , whereas ADAM-12 transgenic are overweight or obese [26] , supporting the critical roles of these molecules in adipose tissue development. Genetic variations in the activities of these proteolytic enzymes is likely to contribute to interindividual variations in the capacity for adipose tissue expansion, allowing the safe storage of lipid in adipocytes in the face of a positive energy balance in some individuals. The improved insulin sensitivity despite increased fat mass of collagen VI knockout mouse [15 ] provides a clear example of this concept.
Role of adipose tissue macrophages
Macrophages normally reside in lean adipose tissue in which they participate in normal remodeling. In obesity, as mentioned previously, macrophages are often found in CLS surrounding dead adipocytes during periods of tissue remodeling [3] . With development of obesity, adipose tissue macrophages (ATMs) are polarized to an M1 inflammatory phenotype and both the number of adipose M1 and the M1/M2 ratio are associated with systemic inflammation and the induction of insulin resistance [27, 28 ] (Fig. 1) . M2 macrophages, which normally reside within adipose tissue, express anti-inflammatory genes (IL-10) and are involved in tissue remodeling. Other work suggests the situation may be more complex. Human ATMs have M2-like surface markers but can produce an excessive amount of proinflammatory cytokines [29] and mixed expression of both proinflammatory and anti-inflammatory characteristics [30 ] . A coincident M2 and M1 phenotype of ATMs was also observed during high-fat diet-induced adipose tissue remodeling in mice [31 ] . These data suggest that ATMs that accumulate within obese adipose tissue acquire particular remodeling phenotypes.
Recently recognized role of T-cells in adipose remodeling
The importance of T-cells in adipose tissue inflammation and remodeling was demonstrated recently, although a nature of details remains controversial [32 ,33 ] . Obese adipose tissue is characterized with decreased numbers of regulatory T-cells (CD4 þ Foxp3 þ ; Treg) and increased numbers of CD8þ T-cells [32 ,34 ] . Selective increases in Treg improve whole-body insulin sensitivity [35 ] . CD8 þ T-cell infiltration may precede macrophage accumulation and may be involved in macrophage differentiation and activation [33 ] . Mast cells may also be important regulators of angiogenesis, T-cell recruitment and remodeling events in obese adipose tissue [36 ] .
Role of blood flow and hypoxia
During development, angiogenesis and adipogenesis are temporally and spatially coupled [37] . Classic studies of blood flow showed a constant blood supply per adipocyte as rats grew spontaneously more obese [38] . However, blood flow per unit adipocyte surface declines with obesity, raising the possibility that oxygen and nutrient delivery to the adipocyte becomes suboptimal. In-vivo imaging studies show that adipose tissue blood flow is discontinuous and leukocyte adhesion, which is increased in obesity, appears to perturb the flow [5 ] . The vasculature of obese adipose tissue may also exhibit abnormal responses to vasodilators (e.g. nitric oxide) or increased permeability [5 , 39, 40 ] . Direct measurements of oxygenation document lower adipose tissue oxygen tension (pO 2 ) with lower capillary density in obese individuals. Further, pO 2 was inversely correlated with proinflammatory markers, suggesting that lower adipose tissue pO 2 could drive adipose tissue inflammation in obesity, consistent with a causal role of the low vascularity for hypoxia, fibrosis, and adipocyte dysfunction [41] . Inhibition of angiogenesis reduces adipose tissue mass [42, 43] and targeting angiogenesis in hypoxia may improve adipose tissue function in obesity. However, the result may be healthy, but more obese individuals.
Adipocyte dysfunction may contribute to the cycle of accelerated adipose tissue remodeling in obesity. Of the two major adipokines, leptin has potent proangiogenic effects [44] and adiponectin may also be proangiogenic [45] . The ability of the adipocyte to upregulate and respond to these hormones, as well as vascular endothelial growth factor, likely determines whether the tissue can maintain normal function in the face of expansion and the stress of hypoxia. Other adipocyte secretory products (metabolites and adipokines) also affect immunocyte recruitment and activation. Increased free fatty acid (FFA), leptin and serum amyloid A (SAA) with reduced adiponectin characterize adipocytes in obese individuals. SAA has been shown to increase migration of monocytes and neutrophils [46] and T-lymphocyte migration and adhesion [47] . SAA expression highly correlates with adipocyte size [48] and thus SAA may be a casual link between the hypertrophy of adipocytes and immunocytes accumulation in obesity. Other secretory and cell adhesion molecules may also play a role in recruitment and activation of immune cells into adipose tissue of obese individuals.
Mechanisms regulating adipose remodeling and its consequences appear to vary among depots. Omental adipose tissue is known to secrete angiogenic compounds and to aid wound healing [49] . Although expression of numerous proinflammatory cytokines is higher in omental adipose tissue, the adipocytes themselves are not especially insulin-resistant. GLUT4 expression and the insulin stimulation of glucose transport as well as rates of triglyceride turnover are in fact higher in visceral [50, 51] than sc adipose tissue. Thus, depot-specific local factors may protect adipocytes from inflammatory stress [52] , and the higher number of CLS in omental vs. sc may not necessarily reflect adipocyte dysfunction or hypoxia.
Thiazolidinediones induce a healthy remodeling of adipose tissue
The thiazolidinediones (TZDs) are antidiabetic drugs that were developed as insulin-sensitizing drugs. TZDs activate PPARg, increase adipogenesis, and may also cause apoptosis of hypertrophied adipocytes [53] , although it is unclear whether the latter is a direct action. The appearance of the new, smaller and more insulinsensitive adipocytes after TZD treatment leads to adipose tissue expansion but improvements in systemic insulin action. TZDs also increase angiogenesis which is required for adipose tissue growth [54] and promote infiltration of M2 into adipose tissue [55] . These data suggest endogenous PPARg ligands may regulate processes that promote the normal healthy remodeling of adipose tissue.
Associations of adipocyte death with metabolic dysfunction in humans
Like the situation in rodents, CLS are also more numerous in visceral (omental) than sc of women and men [3, 8, 56] , but systematic comparisons between the sexes have not been carried out to date. The number of CLS decreases after massive weight loss [57] . Intriguingly, the number of CLS correlates with the level of inflammation (assessed by expression levels of inflammatory genes), a HOMA-IR as a rough reflection of systemic insulin sensitivity, as well as systemic vascular endothelial dysfunction, independent of the level of obesity [56, 58] . Additionally, the numbers of CLS in omental adipose tissue correlate with the severity of hepatic fibroinflammatory lesions [56] and liver fat content [59] . These data suggest macrophage infiltration in adipose tissue contributes to the complications of obesity. Studies are needed to carefully assess how the number of CLS is related to obesity, sex, and depot differences in adipocyte function, and whether there is a functional link to metabolic dysfunction or it is simply a marker for the metabolic syndrome.
Conclusion
The normal growth and expansion of adipocyte size may have no negative consequences if accompanied by flexible ECM and a proportional increase in blood flow and hence oxygenation. However, with overnutrition, if adipocyte hyperplasia does not keep pace with the need to store lipid, excessive adipocyte hypertrophy combined with a limited vasculature expansion may lead to metabolic or hypoxic stress, inflammation and the recruitment and activation of macrophages. Considering the apparently much lower rates of adipocyte death in humans compared to mice, and clear depot and sex differences, the importance of this process as a major driver of adipose tissue inflammation and remodeling in human adipose tissue, and hence the metabolic complications of obesity remains uncertain.
